HikmapharmQA

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company founded in 1978 in Amman, Jordan, and now headquartered in London, UK. It operates in 17 markets globally and is the second largest pharmaceutical company in its regions. Hikma's mission is to make high-quality medicines accessible, emphasizing integrity, quality, and innovation. The company operates through three main segments: Injectables, Generics, and Branded pharmaceuticals. Hikma has a strong focus on sterile injectable products and offers a diverse portfolio that includes generic and branded pharmaceuticals, specialty medications, and ophthalmic products. It has a significant presence in the Middle East and North Africa (MENA) region and has expanded into North America and Europe, with manufacturing facilities in Portugal and Italy. Hikma is committed to healthcare initiatives, participating in government tenders and investing in healthcare capacity building. The company has made strategic acquisitions to enhance its market position and projects growth in its specialty segments, reflecting its focus on higher-margin pharmaceuticals.